MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 160 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2014. The put-call ratio across all filers is 40.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,192,000 | -16.6% | 72,438 | -10.4% | 0.73% | -21.8% |
| Q3 2014 | $1,430,000 | -14.8% | 80,847 | -0.6% | 0.94% | -11.1% |
| Q2 2014 | $1,679,000 | -6.1% | 81,370 | -0.8% | 1.06% | -7.9% |
| Q1 2014 | $1,788,000 | -15.6% | 82,047 | +2.8% | 1.15% | -18.1% |
| Q4 2013 | $2,118,000 | +14.9% | 79,846 | +2.4% | 1.40% | +4.4% |
| Q3 2013 | $1,843,000 | +6.7% | 77,988 | +1.2% | 1.34% | -0.3% |
| Q2 2013 | $1,727,000 | – | 77,096 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |